Original paper
The RESTORE Randomized Controlled Trial
Abstract
Objective: The Rehabilitation Strategies in Esophagogastric cancer (RESTORE) randomized controlled trial evaluated the efficacy of a 12-week multidisciplinary program to increase the cardiorespiratory fitness and health-related quality of life (HRQOL) of esophagogastric cancer survivors. Background: Patients following treatment for esophagogastric cancer are at risk of physical deconditioning, nutritional compromise, and sarcopenia. Accordingly,...
Paper Details
Title
The RESTORE Randomized Controlled Trial
Published Date
Jul 14, 2018
Journal
Volume
268
Issue
5
Pages
747 - 755